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Connective tissue growth factor (CTGF) is a member of the CCN
(Cyr 61, CTGF, Nov) family of secreted proteins that functions in
various biological processes including embryogenesis. CTGF null
mutants die at birth due to defects in lung and bone development.
In the developing pancreas, CTGF is expressed in the blood vessel
endothelium, ductal epithelium and insulin-producing beta cells.
CTGF mutant embryos showed an increased differentiation of
glucagon-positive cells beginning at e13.5 and decreased beta cell
proliferation at e18.5. CTGF transgenic mouse embryos in which CTGF
is over-expressed under the collagen-1 promoter showed an increase
in endocrine mass with a decrease in exocrine mass. Based on these
findings we hypothesize that CTGF functions in endocrine cell
specification and beta cell proliferation. We are generating endo-
crine-specific doxycycline-inducible bigenic mice to study the effect
of CTGF over-expression on endocrine differentiation and beta cell
proliferation at different stages of development and in adults.
Although CTGF is expressed in beta cells during development it is
no longer expressed in adult islets. However, CTGF is re-expressed in
the islets of pregnant females. During pregnancy islets are known to
undergo adaptive changes including enhanced glucose-stimulated
insulin secretion and beta cell proliferation. Preliminary studies with
CTGF heterozygous females showed glucose intolerance during
pregnancy suggesting a role in beta cell function and/or beta cell
mass expansion. Endocrine-specific CTGF null mice, will be used to
study the effect of CTGF on islet function during pregnancy.
doi:10.1016/j.ydbio.2009.05.308
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Bones and cartilages that make up craniofacial structures, such as
the jaw, are formed by neural crest cells that have migrated to the
pharyngeal arches early in craniofacial development. These cells
receive many patterning cues from surrounding cells of the
pharyngeal ectoderm, mesoderm, and endoderm, leading to the
formation of correct skeletal structures. Genetic studies on zebrafish
mutants with anterior arch defects revealed that Endothelin-1 (Edn1)
is required for the development of ventral craniofacial structures. Loss
of edn1 through mutation or morpholino-mediated knockdown
results in severe reduction of ventral cartilage components, possibly
through decreased cell proliferation or increased cell death of neural
crest-derived cells in the pharyngeal arches. Exogenous EDN1 has
been shown to increase cell proliferation and decrease cell death in
cancer cell lines. Here, we reveal through BrdU labeling that Edn1
functions to promote cell proliferation during early pharyngeal arch
development in a spatio-temporal manner. Edn1-dependent cell
proliferation may be limited to early pharyngeal arch development as
the effect of edn1 loss is stronger at earlier stages in edn1 MO treated
zebrafish embryos. In addition, Edn1 functions as a survival factor, as
loss of edn1 leads to increased cell death detected by TUNEL staining
during early pharyngeal arch development. From these results, we
conclude that edn1 patterns ventral skeleton by controlling cell
proliferation and cell death of the neural crest-derived cells early in
pharyngeal arch development. (Supported by NIH grant F32
DE0190565-01A1).
doi:10.1016/j.ydbio.2009.05.309
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